Remove Doctors Remove Licensing Remove Sales
article thumbnail

Dr Reddy’s jumps on medical cannabis train, buying Nimbus Health

pharmaphorum

Legislation is already in place allowing companies to grow the plant for medicinal purposes under license, doctors have been able to prescribe it since 2017 with full reimbursement from health insurers.

Licensing 119
article thumbnail

NEW FEXOFENADINE over the counter – Allevia tablets

Druggist

The Government recently announced the reclassification of fexofenadine 120mg, which will be available as General sale Medication (GSL), sold as branded products – Allevia 120mg tablets. When to speak to a pharmacist or a doctor before taking Allevia tablets? Until now, fexofenadine was a prescription-only medication.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Digital health player UpHealth swells with three-way merger

pharmaphorum

The three-way deal combines UpHealth – which provides patient care management, telemedicine and digital pharmacy services and gives its name to the new group – with CloudBreak, which provides a video consultation platform for doctors and patients. The largest by far was the $18.5

article thumbnail

ASCO22: Enhertu aces key HER2-low test in breast cancer

pharmaphorum

Approval in that broader patient range could unlock $3 billion in additional sales for Enhertu, according to analysts at Credit Suisse. billion upfront to license rights to Enhertu in a deal that could be worth up to $6.9 billion to Daiichi Sankyo if all the ADC’s development and sales objectives are achieved. AZ paid $1.4

HR 105
article thumbnail

NICE says yes to Novartis’ multiple sclerosis therapy Kesimpta

pharmaphorum

“People living with MS need access to a range of different treatment options so they can work with their doctor to find the one that’s best for them,” said David Martin, chief executive of the Multiple Sclerosis Trust. billion in sales in 2028. billion by 2028. It was backed by NICE for NHS use in July 2018.

Sales 111
article thumbnail

AbbVie spies potential in Regenxbio eye disease gene therapy

pharmaphorum

AbbVie has expanded its ophthalmology pipeline via a licensing deal with Regenxbio, paying $370 million upfront to get its hands on a gene therapy for wet age-related macular degeneration (AMD) and other eye diseases. AbbVie – which is also putting up $1.38 The transaction is expected to close by the end of 2021.

article thumbnail

Can you get melatonin over the counter in the UK?

Druggist

In the UK, licensed forms of melatonin are prescribed either for the management of insomnia in adults over 55 years of age or to help with jet lag. The supply of prescription-only medicines is possible after a prescription (NHS or private prescription) is issued to the patient by a doctor or another qualified prescriber. .